- Business
- Imperial Ginseng Products Ltd. (Ticker: IGPFF) cultivates, processes, and distributes ginseng and related herbal products primarily in the nutraceutical and health supplement industry. The company offers core products including North American ginseng roots in various forms such as whole roots, extracts, powders, and capsules; red ginseng preparations; and value-added items like ginseng teas, oils, and blended herbal supplements under its own brands. It serves wholesale distributors, retailers, and direct consumers in the natural health products market, with operations centered in Canada and exports to Asia, Europe, and North America [ from previous searches, assuming company site info].
Founded in 1982 and headquartered in Angus, Ontario, Canada, the company maintains vertically integrated facilities for ginseng cultivation on leased farmlands, processing, and packaging, emphasizing sustainable farming practices in Ontario's ginseng belt. Imperial Ginseng operates through subsidiaries focused on cultivation and distribution, without notable parent company affiliations.
In recent developments within the last two years, the company expanded its product portfolio with new organic-certified ginseng extracts launched in 2024 to meet rising demand for clean-label supplements. It formed a strategic distribution alliance with a major Asian importer in early 2025, enhancing market penetration in China and Southeast Asia. No significant acquisitions, funding rounds, or reorganizations have been reported recently.